Home » Newsletters » BioWorld

BioWorld

Sep. 27, 1991

View Archived Issues

ANALYST DOWNPLAYS GM-CSF PATENT NEWS

CHIRON/CETUS MERGER PASSES FTC DEADLINE

CENTOCOR RAISES SIZE OF DEBENTURES

EPITOPE GETS GRANT FOR HIV TEST

MGI GETS RIGHTS TO PILOCARPINE MOUTHWASH

HEMACARE EXTENDS WARRANT EXPIRATION

OXFORD COMPLETES $8M FINANCING

SBIR GRANTED FOR AMYLIN MABS

FDA PANEL RECOMMENDATION SPURS CHIRON

SUITS OPPOSE GI MERGER WITH AHP

COMBINATION TEST APPROVED FOR HIV-1, 2

MULTIDRUG STRATEGY TO COMBAT AIDS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...